NVE Corporation Reports Second Quarter Results and Announces Quarterly Dividend

NVE's quarterly revenue and net income both declined despite R&D growth.

What the company is saying

NVE Corporation (NASDAQ:NVEC) is reporting its financial results for the quarter ended September 30, 2026, focusing on headline figures for revenue, net income, and earnings per share. The company frames the 8% year-over-year revenue decline as primarily due to a 9% drop in product sales, while highlighting a 25% increase in contract research and development revenue as a partial offset. The tone is factual, with no forward-looking statements or promotional language. The announcement emphasizes the contrasting trends between product sales and R&D revenue, but does not elaborate on underlying operational factors or future plans. No executive quotes or additional commentary are provided. The messaging is limited to period-over-period financial performance and the immediate causes for the revenue shift.

What the data suggests

The disclosed figures show total revenue for the quarter at $5.83 million, down 8% from $6.35 million in the prior-year period. Product sales fell 9%, which was only partially offset by a 25% increase in contract research and development revenue. Net income declined 4% to $3.17 million, and earnings per share were $0.65. The data indicates that growth in contract R&D was not enough to compensate for the larger decline in product sales, resulting in overall weaker financial performance. The company provides clear headline numbers and a basic breakdown of revenue sources, but does not disclose cash flow, segment margins, or balance sheet details. The evidence points to a negative trend in core product sales, with R&D growth providing only limited relief.

Analysis

The announcement is a straightforward disclosure of quarterly financial results, with all key claims supported by explicit numerical data. There is no forward-looking language or promotional tone; the release simply reports an 8% decline in revenue and a 4% decline in net income, with a breakdown of the drivers behind these changes. No claims are made about future performance, strategic initiatives, or long-term benefits. The tone is factual and proportionate to the results, which reflect a deterioration in financial performance. There is no evidence of narrative inflation or overstatement, and no large capital outlay or deferred benefit is mentioned.

Risk flags

• ●A 9% decline in product sales signals potential weakness in the company's core business, which could persist if not addressed. This matters because product sales are likely the primary revenue driver, and continued declines may pressure overall profitability.
• ●The company's partial reliance on contract research and development revenue, which increased 25%, introduces volatility if these contracts are not recurring or predictable. If R&D growth slows or contracts lapse, there may be limited offset to further product sales declines.
• ●The announcement omits detail on cash flow, segment margins, or balance sheet strength, limiting visibility into underlying financial health and the company's ability to weather further revenue declines.

Bottom line

NVE Corporation's latest quarterly results show both revenue and net income declining year-over-year, with product sales down 9% and total revenue falling 8% to $5.83 million. The 25% growth in contract research and development revenue was not enough to counteract the weakness in product sales. Net income dropped 4% to $3.17 million, and earnings per share were $0.65. The company provides a clear but limited snapshot, with no forward-looking guidance or detail on operational initiatives to reverse the trend. Investors should recognize that the core business is under pressure, and the sustainability of R&D revenue growth is uncertain. The most important takeaway is that headline financial performance is deteriorating, and further disclosure would be needed to assess whether this is a temporary setback or a longer-term challenge.

Announcement summary

(NASDAQ:NVEC) NVE Corporation announced financial results for the quarter ended September 30, 2026. Total revenue for the second quarter of fiscal 2027 was $5.83 million, representing a decrease of 8% compared to $6.35 million in the prior-year quarter. The revenue decrease was attributed to a 9% decrease in product sales, which was partially offset by a 25% increase in contract research and development revenue. Net income for the second quarter of fiscal 2027 was $3.17 million, a decrease of 4% from the prior-year quarter. Earnings per share for the quarter were $0.65. The company provided a breakdown of revenue sources, noting the contrasting trends in product sales and contract R&D revenue. The announcement covers the company's financial performance for the second quarter of fiscal 2027, with explicit figures for revenue, net income, and earnings per share. The results reflect both challenges in product sales and growth in contract research and development activities.

Disagree with this article?